Just a moment, the page is loading...
 
GBT

The GBT Foundation

The GBT Foundation is a not-for-profit organization that seeks to improve the health and well-being of underserved patient communities around the world.

Our giving is focused on advancing health equity and enhancing education, empowerment, and access to care for people living with sickle cell disease.

Learn More

The Access to Excellent Care for Sickle Cell Patients grant will be awarded to institutions for programs with a focus on patient access to care, supporting SCD clinics and transition of care from pediatric to adult.  Grants will be awarded to organizations seeking to provide innovative and sustainable health care solutions that support SCD patients, caregivers and the overall SCD community. U.S.-based nonprofit organizations dedicated to SCD with a 501(c)(3) public charity status are eligible to receive grant awards of up to $100,000 during a 12-month period.

Learn More

The Access to Care Empowerment (ACCEL) for Sickle Cell Grants Program is an opportunity dedicated to supporting the work that community-based organizations do for patient empowerment and support, peer-to-peer education, healthcare navigation for patients and caregivers and capacity building for partner organizations. U.S.-based nonprofit organizations dedicated to SCD with a 501(c)(3) public charity status are eligible to receive grant awards of up to $50,000 during a 12-month period.

The Access to Excellent Care for Sickle Cell Patients grant will be awarded to institutions for programs with a focus on patient access to care, mental health capacity building, supporting SCD clinics and transition of care from pediatric to adult.  Grants will be awarded to organizations seeking to provide innovative and sustainable health care solutions that support SCD patients, caregivers and the overall SCD community. U.S.-based nonprofit organizations dedicated to SCD with a 501(c)(3) public charity status are eligible to receive grant awards of up to $100,000 during a 12-month period.

Learn More



  • © Global Blood Therapeutics, Inc. 2022
  • About
  • Contact
  • Privacy Policy
  • Terms of Use